AtriCure, Inc. (ATRC)
56.07
-1.71
(-2.96%)
USD |
NASDAQ |
Oct 16, 16:00
56.00
-0.07
(-0.12%)
After-Hours: 20:00
AtriCure Cash from Investing (Quarterly) : -3.766M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.766M |
| March 31, 2026 | -3.852M |
| December 31, 2025 | -2.602M |
| September 30, 2025 | -2.605M |
| June 30, 2025 | -7.662M |
| March 31, 2025 | -1.681M |
| December 31, 2024 | -14.69M |
| September 30, 2024 | 4.392M |
| June 30, 2024 | 30.89M |
| March 31, 2024 | 9.644M |
| December 31, 2023 | -2.786M |
| September 30, 2023 | 11.87M |
| June 30, 2023 | -16.08M |
| March 31, 2023 | 28.81M |
| December 31, 2022 | 7.002M |
| September 30, 2022 | -3.239M |
| June 30, 2022 | 20.52M |
| March 31, 2022 | 19.72M |
| December 31, 2021 | 1.077M |
| September 30, 2021 | -25.10M |
| June 30, 2021 | -16.06M |
| March 31, 2021 | 63.59M |
| December 31, 2020 | -1.98M |
| September 30, 2020 | -58.74M |
| June 30, 2020 | -112.81M |
| Date | Value |
|---|---|
| March 31, 2020 | 17.33M |
| December 31, 2019 | -2.601M |
| September 30, 2019 | -9.633M |
| June 30, 2019 | -0.93M |
| March 31, 2019 | 11.02M |
| December 31, 2018 | -70.83M |
| September 30, 2018 | -0.601M |
| June 30, 2018 | -9.732M |
| March 31, 2018 | -4.245M |
| December 31, 2017 | 1.065M |
| September 30, 2017 | -2.599M |
| June 30, 2017 | -0.431M |
| March 31, 2017 | 5.726M |
| December 31, 2016 | 6.813M |
| September 30, 2016 | -5.015M |
| June 30, 2016 | -20.87M |
| March 31, 2016 | 6.996M |
| December 31, 2015 | -2.735M |
| September 30, 2015 | -9.041M |
| June 30, 2015 | -1.282M |
| March 31, 2015 | 2.557M |
| December 31, 2014 | -9.436M |
| September 30, 2014 | -5.139M |
| June 30, 2014 | -23.46M |
| March 31, 2014 | 7.414M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -673.00M |
| Boston Scientific Corp. | -1.956B |
| AngioDynamics, Inc. | -3.148M |
| Alphatec Holdings, Inc. | -22.72M |
| Baxter International, Inc. | -117.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 22.19M |
| Cash from Financing (Quarterly) | 3.262M |
| Free Cash Flow | 53.11M |
| Free Cash Flow Per Share (Quarterly) | 0.3771 |
| Free Cash Flow to Equity (Quarterly) | 19.12M |
| Free Cash Flow to Firm (Quarterly) | 19.68M |
| Free Cash Flow Yield | 1.96% |